Cargando…
An AAV capsid increases transduction of striatum and a ChAT promoter allows selective cholinergic neuron transduction
Adeno-associated virus (AAV) vectors are currently the most efficient option for intracranial gene therapies to treat neurodegenerative disease. Increased efficacy and safety will depend upon robust and specific expression of therapeutic genes into target cell-types within the human brain. In this s...
Autores principales: | Santoscoy, Miguel C., Espinoza, Paula, De La Cruz, Demitri, Mahamdeh, Mohammed, Starr, Jacqueline R., Patel, Nikita, Maguire, Casey A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285237/ https://www.ncbi.nlm.nih.gov/pubmed/37359416 http://dx.doi.org/10.1016/j.omtm.2023.05.001 |
Ejemplares similares
-
AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear
por: Ivanchenko, Maryna V., et al.
Publicado: (2021) -
Single amino acid insertion allows functional transduction of murine hepatocytes with human liver tropic AAV capsids
por: Cabanes-Creus, Marti, et al.
Publicado: (2021) -
Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS
por: Kanaan, Nicholas M., et al.
Publicado: (2017) -
Capsid Serotype and Timing of Injection Determines AAV Transduction in the Neonatal Mice Brain
por: Chakrabarty, Paramita, et al.
Publicado: (2013) -
Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction
por: Fitzpatrick, Zachary, et al.
Publicado: (2018)